CEO Adam Sachs anticipates starting the clinical trial later this year, receiving positive feedback from clinical sites excited about the system. Supply chain issues are resolved, and first-in-human trials are set for 2025. Version 1.0 integration involved tests showing system reliability and disposable instrument improvements.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay